* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download cis-Regulatory Elements and trans-Acting Factors
Long non-coding RNA wikipedia , lookup
Oncogenomics wikipedia , lookup
Epigenetics in stem-cell differentiation wikipedia , lookup
DNA vaccination wikipedia , lookup
Genetic engineering wikipedia , lookup
Nutriepigenomics wikipedia , lookup
Gene expression profiling wikipedia , lookup
Microevolution wikipedia , lookup
Epigenetics of diabetes Type 2 wikipedia , lookup
Polycomb Group Proteins and Cancer wikipedia , lookup
Gene therapy wikipedia , lookup
Point mutation wikipedia , lookup
Genome editing wikipedia , lookup
History of genetic engineering wikipedia , lookup
Primary transcript wikipedia , lookup
Designer baby wikipedia , lookup
Vectors in gene therapy wikipedia , lookup
No-SCAR (Scarless Cas9 Assisted Recombineering) Genome Editing wikipedia , lookup
Artificial gene synthesis wikipedia , lookup
Mir-92 microRNA precursor family wikipedia , lookup
Gene therapy of the human retina wikipedia , lookup
Therapeutic gene modulation wikipedia , lookup
764 Original Contributions cis-Regulatory Elements and trans-Acting Factors Directing Basal and cAMP-Stimulated Human Renin Gene Expression in Chorionic Cells Pascale Borensztein, Stephane Germain, Sebastien Fuchs, Josette Philippe, Pierre Corvol, Florence Pinet Downloaded from http://circres.ahajournals.org/ by guest on August 3, 2017 Abstract Much knowledge was accumulated in the regulation of plasma renin activity and renin secretion during recent years. However, the mechanisms of renin gene transcription, especially for the human gene, have been poorly studied because of the lack of cell lines expressing renin. Cells derived from chorion tissue were used to study renin gene transcription because these cells express renin and regulate renin secretion in a similar way to JG cells. The present study was performed to determine the cis-regulatory elements and the trans-acting factors involved in human renin gene expression using chorionic cells. Transient DNA transfections were performed with various constructs containing the 5'-flanking region of the human renin gene. 5'-Deletion analysis of the human renin promoter (from -2616 to -67 bp) revealed the presence of two proximal negative cis-regulatory elements between -374 and -273 bp and between -273 and -137 bp. These elements were not present in a non-renin-producing cell line, JEG-3 cells. DNase I footprinting revealed that two sequences located within these regions bind trans-factors present in chorionic cellular nuclear extract: AGE3-like sequence (-293/-273) and apolipoprotein Al regulatory pro- tein-1-like sequence (-259/-245). The first 110 bp of the renin promoter were sufficient to direct specific expression in chorionic cells and contained two footprints sharing homology with ets (-29/-6) and pituitary-specific factor (Pit-1) (-70/-62) sequences. Furthermore, one footprint (-234/-214) contained the sequence TAGCGTCA, which shares strong homology to the cAMP-responsive element (CRE) binding site. Gel shift analysis showed specific DNA/protein complexes within this region, which were displaced by the somatostatin consensus CRE. Finally, luciferase analysis of 5'-deletion mutant revealed that -273 to +16 bp of the renin promoter was sufficient to confer complete forskolin stimulation, whereas deletion to -130 (deletion of the CRE) decreased cAMP responsiveness by 50% and those to -67 bp (deletion of the CRE and Pit-1-like sequences) suppressed it. Thus, these latter two sequences probably act together to confer complete cAMP responsiveness. (Circ Res. 1994;74:764-773.) Key Words * renin gene * chorionic cells * luciferase cis-acting elements * trans-acting factors * cAMP-responsive element * pituitary-specific factor * ets R enin (E.C.3.4.23.15), an aspartyl protease that cleaves angiotensin I from angiotensinogen in the rate-limiting step of the renin-angiotensin system, plays a major role in blood pressure regulation and fluid and electrolytic homeostasis. During recent years, much knowledge has accumulated concerning the numerous factors influencing renin secretion, such as f3-adrenergic agonists, peptidic hormones, and drugs.' Several intracellular mediators influencing renin release, such as cAMP, cGMP, and intracellular calcium, have also been identified.2 Most of these studies were performed in isolated perfused kidney, kidney slices, or juxtaglomerular cell cultures because kidney-derived renin represents most of the circulating enzyme. Another important step in the control of renin secretion is the rate of transcription of the renin gene. However, studies examining this step are difficult to perform, in particular because of the lack of established renin-producing cell lines. The transcriptional regulatory elements of the mouse renin genes have been largely characterized. One of the interesting features of this species is the presence of a duplicated renin gene in some strains, eg, DBA/2J. The RenJ gene is expressed mainly in the kidney, whereas the Ren2 gene is expressed in both the kidney and the submandibular gland. Nakamura et a13 have shown the presence of a negative regulatory element in the 5'flanking region of both mouse renin genes; this element is functional in the Renl but not the Ren2 gene, probably because of the interference by an adjacent 150-bp insertion in this latter gene.4 This difference in functionality may play a role in the differential expression of the renin genes in the submandibular gland. First, this negative regulatory element could bind a specific nuclear protein, present in the submandibular gland, resulting in the inhibition of Reni expression in this tissue.4 Second, the high expression of submandibular Ren2 could be due to the nonfunctionality of the negative regulatory element.4 Recently, Tamura et al' identified, by transient DNA transfection, two positive cis-acting sequences located within a large insertion in the mouse gene and not present in the human gene,6 suggesting that transcriptional regulation of the renin gene could differ between species. In addition, they showed that renin gene expression depends strongly on the cell model used and on the presence or absence of trans-acting factors in these cells. Very little is known about the mechanisms controlling human renin gene expression, mainly because of the lack of established renin-producing cell lines. Human Received October 8, 1993; accepted January 10, 1994. From INSERM Unit 36, College de France, Paris. Correspondence to Dr Florence Pinet, INSERM Unit 36, College de France, 3 rue d'Ulm. 75005 Paris. France. Borensztein et al cis-Acting Elements in the Human Renin Gene Downloaded from http://circres.ahajournals.org/ by guest on August 3, 2017 renin is expressed in many cell types,7 but its expression is particularly high in juxtaglomerularl and chorionic cells.8-'0 Juxtaglomerular cells are difficult to isolate and to culture, and they lose their ability to produce renin after a single passage.1',12 Attempts to immortalize these cells by the use of different SV40 mutants resulted in limited expression of the human renin gene.'3 Although these cells allowed the study of some of the mechanisms involved in renin secretion, they cannot be used for renin gene expression studies. Chorion tissue represents the second major site of production, after kidney, in human tissues.10 Moreover, chorionic cells in primary and secondary cultures produce large quantities of renin, predominantly in the prorenin form, and are easily accessible.14 Renin regulation in this model was studied and showed a role of cAMP and protein kinase C.15 This is similar to the regulation demonstrated in primary cultures of JG cells.2 Therefore, these cells may provide a useful model for studying the regulation of renin gene expression. Using transient DNA transfections, Duncan et a116 reported that human chorionic cells are able to use the first 600 bp of the renin promoter to direct chloramphenicol acetyl transferase (CAT) expression without needing an enhancer. Other studies have been performed using the JEG-3 cell line, which is derived from a human choriocarcinoma.17'18 However, this model has several limitations: these cells do not express the renin gene,18'19 and analysis of the 5'-flanking region of the gene required the use of the herpes simplex virus thymidine kinase (tk) promoter to direct CAT expression.'7'18 There is a single recent study on a trans-acting factor controlling human renin gene expression showing that nuclear extracts isolated from a rat lactotrope precursor cell line (GC) interact with a pituitary-specific factor (Pit-1) binding site consensus sequence.20 Since Pit-1 is expressed only in pituitary cells,21 the functionality of this cis-acting sequence remains to be shown in reninexpressing cells. The present study was performed to determine the cis-regulatory elements and the trans-acting factors involved in human renin gene expression, using reninproducing cells derived from chorionic tissue. The promoter elements involved in the transcription of the human renin gene in chorionic cells were localized by different approaches. Luciferase assays in human chorionic cells transiently transfected with constructs made by sequential deletions of the promoter region allowed the mapping of basal and cAMP-induced renin gene expression. Footprinting analysis of the human renin promoter, reported here for the first time, revealed the presence of several cis-regulatory elements within the proximal renin promoter. These consisted of sequences with varying degrees of homology with, respectively, the Pit-i-like binding site consensus sequence, the cAMPresponsive element (CRE), the apolipoprotein Ai regulatory protein-1 (ARP-1) binding site, an ets binding site, and the AGE3 sequence on the angiotensinogen gene. Finally, gel mobility shift analysis showed that the CRE sequence specifically binds nuclear extracts from chorionic cells. Materials and Methods Materials All DNA-modifying enzymes were purchased from New England Biolabs. Oligonucleotides were synthesized with an 765 Applied Biosystems synthesizer. Reverse transcriptase, Taq DNA polymerase, ATP, and culture media were obtained from Boehringer Mannheim. [a-'2P]dCTP and [y-`P]ATP were purchased from Amersham. Purified luciferase from Photinus pyralis, synthetic D-luciferin, and forskolin were obtained from Sigma. Cell Culture and Transfections Primary and secondary cultures of human chorionic cells were prepared essentially as previously described.'4 Briefly, the chorion was separated from other membrane layers and digested by successive incubation periods in 0.05% collagenase and 0.05% trypsin. After filtration (45-,um nylon mesh) and centrifugation, the cell pellets were resuspended in Dulbecco's modified Eagle's medium (DMEM) supplemented with streptomycin (10 gg/mL), penicillin (10 UI/mL), 4 mmol/L glutamine, and 10% fetal calf serum (FCS) and then plated onto the 25-cm2 flasks containing 4 mL DMEM. When the cells were confluent, the first subculture was carried out: chorionic cells were treated with 0.05% collagenase and then with 5 mmol/L EDTA. The cell suspension was centrifuged, and the resultant cell pellets were resuspended in DMEM supplemented as above and then plated at a 1:4 dilution into similar flasks containing DMEM. The human choriocarcinoma cell line (JEG-3) was obtained from the American Type Culture Collection and maintained in DMEM supplemented as above. Transient DNA transfections into chorionic and JEG-3 cells were performed by calcium phosphate precipitation22 using 25 ,ug DNA per plate consisting of 5 gg RSV-CAT (as an internal control for plate-to-plate transfection efficiency) and 20 jig renin luciferase reporter plasmid. After overnight incubation, the cells were treated for 2 minutes with a 15% glycerol shock. The medium was then replaced with serum-free defined medium containing 50% Dulbecco's medium and 50% Ham F12 supplemented with streptomycin (10 gg/mL), penicillin (10 UI/mL), selenium (3x 10`8 mol/L), palmitic acid (1 gg/mL), oleic acid (5 gg/mL), linoleic acid (5 gg/mL), bovine serum albumin free fatty acid (1 mg/mL), transferrin (5 ,ug/mL), and glutamine (4 mmol/ L). The cells were incubated for 24 hours with or without forskolin 10` mol/L, and then the luciferase activity was determined and the CAT immunoassay performed. Direct renin immunoassay was performed on culture medium by enzyme-linked immunosorbent assay (ELISA) with a sensitivity limit of 20 pg/mL.23 Reporter Assays Transfected cells were washed three times with phosphatebuffered saline (PBS), lysed by addition of 0.1 mL 1% Triton, 10 mmol/L MgCl2, 1 mmol/L EDTA, 25 mmol/L Tris-phosphate (pH 7.8), 15% glycerol, 1 mmol/L dithiothreitol (DTT), and 0.2 mmol/L phenylmethylsulfonyl fluoride, and harvested by scraping. The lysates were transferred to Eppendorf tubes, and after centrifugation, the supernatant was saved. Luciferase activity was measured by a liquid scintillation counter (model 1211 Rackbeta, LKB). Luminescence was integrated for 1 minute after addition of 150 ,umol/L luciferin and 400 gmol/L ATP.24 Quantitative determination of CAT was performed by a sandwich enzyme immunoassay (Boehringer Mannheim). During the first step, CAT contained in cell extracts binds specifically to modules coated with anti-CAT antibodies. Then, a digoxigenin-labeled anti-CAT antibody is bound to the fixed CAT, and during the last step, the digoxigenin-labeled anti-CAT antibody is detected by a peroxidase-labeled antidigoxigenin antibody. Plasmid Construction Human renin gene fragments were isolated from the two plasmids phrnCAT30 and phrnCAT06, kindly provided by Dr Fukamizu (University of Tsukuba, Japan) and derived from the plasmid subclone AHRn88.25 The plasmid pRSVL, desig- 766 Circulation Research Vol 74, No 5 May 1994 Downloaded from http://circres.ahajournals.org/ by guest on August 3, 2017 nated here as pRSV-luciferase and in which luciferase transcription is driven by the Rous sarcoma virus long-terminal promoter, was provided by Dr Swesh Subramani (version LpJD201).26 The promoterless plasmid (BS luci) was constructed by subcloning a HindIII/BamHI-digested fragment of LpJD201 (corresponding to the intronless luciferase construct with the SV40 small t antigen intron and an SV40 polyadenylation signal) into the polylinker region of the plasmid BlueScript SK (Stratagene). The plasmids p582+ and p582- were constructed as follows: a 598-bp fragment of the human renin gene (-582 to + 16) was isolated by Bgl II/HindIll digestion of phrnCATO6 and subcloned in either orientation into the HindlIl site of BS luci. The resulting p582+ plasmid contained nucleotides -582 to + 16 of the renin gene followed by the luciferase coding sequence. The plasmid containing the antisense insert (+16 to -582) was designated as p582-. The plasmid p892+ was constructed as follows: a 908-bp fragment of the human renin gene (-892 to +16) was isolated by HindIII digestion of phrnCAT30 and inserted into the HindlIl site of BS luci. The plasmid p2616+ was constructed by isolating a 2632-bp fragment of the human renin gene (-2616 to +16) by Bgl II/BamHI/Pst I digestion of phrnCAT30 and inserted into the HindIII site of BS luci. 5-Deletion mutants were generated by linearization of the p582+ plasmid by Xho I and Apa I, followed by exonuclease III digestion, S1 nuclease digestion, repair, and self-ligation. The 5-extent of the exonuclease III digestion is given in nucleotide pairs corresponding to the published sequence.25 The plasmid p110- was constructed as follows: a 127-bp fragment (-110 to + 16) of the renin gene was isolated by Kpn I and Hindlll digestion of the plasmid p110+ (previously obtained by the exonuclease III digestion above) and inserted into the Hindlll site of BS luci. All constructions were verified by the dideoxy sequencing method (Sequenase Version 2.0 DNA Sequencing Kit, USB). Reverse Transcriptase Reaction and Polymerase Chain Reaction Total RNA was extracted from chorionic and JEG-3 cells by the method of Chomczynski and Sacchi.27 Total RNA (500 and 50 ng) was used to prepare cDNA with the M-MLV reverse transcriptase (200 U/,uL, GIBCO-BRL) in the appropriate buffer (Boehringer Mannheim) in the presence of 7.5 mmol/L oligodT, 0.5 U/,L of the RNase inhibitor rRNasin (40 000 U/mL, Promega), 50 mmol/L DTT, 1 ,ug yeast tRNA, and 2.5 mmol/L of each deoxyribonucleotide. After 1 hour of incubation at 37°C, the reaction was stopped by heating the samples for 2 minutes at 95°C. The polymerase chain reaction (PCR) was carried out as described by Caroff et al.28 Briefly, 3 ,uL of the final cDNA solution was mixed with 1 ,uL (10 pmol) of both primers, 4.5 4L of 25 mmol/L MgCl2 solution, 1 ,L of a 25 mmol/L solution of each deoxyribonucleotide, 5 ,uCi of [a-32P]dCTP, 14 ,uL H20, and 2.5 ,L of 10x PCR buffer (supplied with 1.25 U of Taq polymerase). Thirty cycles of PCR were performed, consisting of denaturation at 94°C, annealing at 48°C, and extension at 72°C. After PCR, polyacrylamide gel electrophoresis was performed with the amplification products originating from the renin mRNA, followed by autoradiography. To avoid amplification of genomic DNA coding for renin, the two primers 5'(GTGTCTGTGGGGTCATCCACCTTG)3' and 5'(GGATTCCTGAAATACATAGTCCGT)3' were chosen, the first sequence being present in exon 7 of the renin gene and the second spanning the exon 8/exon 9 border. Quantitative reverse transcriptase PCR was also carried out as described previously28 by use of an internal standard. Serial dilutions of total RNA (from 500 to 30 ng) from chorionic and JEG-3 cells were used with a fixed amount of internal standard (10 pg) to prepare cDNA before PCR. Bands corresponding to PCR products were excised and counted in a 8-counter. Primer Extension Analysis Total RNA was isolated from human chorionic cells, after transfection as described above with the plasmids BS luci, pS82+, and p110+, according to the method of Chomczynski and Sacchi.27 Primer extension reaction was carried out according to the protocol of the AMV reverse transcriptase primer extension system (Promega). Briefly, RNA was resuspended in 5 ,uL H20 and incubated with 1 uL (100 fmol) of 32P-labeled luciferase primer (corresponding to the sequence +37 to +63 of the luciferase gene) and 5 pL of AMV primer extension 2X buffer. Primer and RNA were annealed by heating at 85°C for 5 minutes, then at 60°C for 2 hours. AMV reverse transcriptase was added to the same buffer with sodium pyrophosphate (6 mmol/L) and incubated at 42°C for 1 hour. The reaction was stopped by addition of loading dye, and the primer extension products were analyzed on denaturing 8% polyacrylamide/7 mol/L urea gel. Preparation of Nuclear Extracts and DNase I Footprinting Assays Human chorionic cell nuclear extracts were prepared as previously described.29 The -336 to + 16 fragment of the renin gene promoter was isolated by Avr II/Hindll digestion of the p582+ plasmid and inserted into the EcoRV site of BlueScript SK. The synthetic DNA fragment corresponding to -336 to + 16 was obtained by PCR amplification using the Blue-Script SK and KS universal primers. The SK or KS primer was labeled with [y-32PJATP and T4 polynucleotide kinase before PCR amplification. Footprint analysis was performed in a 10 ,L reaction mixture containing 4 mmol/L MgC12, 4 mmol/L spermidine, 10 mmol/L HEPES (pH 7.9), 50 mmol/L KCl, 0.1 mmol/L EDTA, 0.1 mmol/L EGTA. 2.5% glycerol, 0.5 ,ug of double-stranded poly(dI-dC), 30 ,ug of nuclear extract, and 15 000 cpm of end-labeled fragment. After 20 minutes of incubation at 4°C, 2 ,L of DNase I (Boehringer Mannheim, 10 IU/,uL) at various dilutions ranging from 1150 to 1/400 was added, and digestion was allowed to proceed for 1 minute at 20°C. The reaction was stopped by addition of 30 pL of a solution containing 50 mmol/L EDTA, 0.1% sodium dodecyl sulfate, 0.2 mg/mL yeast tRNA, and 10 mg/mL of proteinase K. The reaction mixture was incubated for 45 minutes at 42°C. The DNA was extracted once with phenol/chloroform, precipitated with 2 volumes of ethanol, resuspended in 98% formamide dye, and electrophoresed on a 6% acrylamide/7 mol/L urea sequencing gel. Gel Mobility Shift Assays The following double-stranded synthetic oligonucleotide, corresponding to the -234 to -200 renin promoter (containing the CRE-like sequence, underlined), was used for gel shift analysis (only the + strand is shown): REN, 5'-GAGGGCTGCTAGCGTCACTGGACACAAGATTGCTTT-3'. The following double-stranded oligonucleotide of the rat somatostatin promoter containing the consensus CRE30 was used as a competitor: SMS, 5'-CTGGGGGCGCCTCCTTGGCTGCTGACGTCAGAGAGAGAG-3'. The REN oligonucleotide was end-labeled with [y-32PJATP and T4 polynucleotide kinase. Nuclear extract (7 ,mg) was incubated for 15 minutes at 4°C in 18 4L of a reaction mixture containing 10 mmol/L HEPES (pH 7.8), 1 mmol/L Na2HPO4 (pH 7.2), 0.1 mmol/L EDTA, 50 mmol/L KCI, 4 mmol/L MgC12, 4 mmol/L spermidine, 2.5% glycerol, 2 ,ug of double-stranded poly(dI-dC), 1 ,ug of salmon sperm DNA, and 20 000 cpm of labeled double-stranded renin oligonucleotide in the presence or absence of 2- to 50-fold excesses of competitor oligonucleotides. The protein-DNA complexes were analyzed by nondenaturing electrophoresis through 6% polyacrylamide gels run in 0.25 x Tris borate EDTA. Statistical Analysis All results are given as mean±+SEM. Levels of significance were calculated by Student's t test; P<.05 was considered significant. Borensztein et al cis-Acting Elements in the Human Renin Gene 767 % relative luciferase activity 0 2 4 +16 L p2616. =W p2616 -2676 6 * 10 8 * -2616 +16 were assayed in chorionic (stippled bars) and JEG-3 cells (solid bars). Luciferase activity was normalized to co- -892 -*p98~p892+ +16 Wuci -582 - p582* -582 ___6______lu ~ci~ 16 p 582 Results Downloaded from http://circres.ahajournals.org/ by guest on August 3, 2017 Human Renin Gene Expression in Transfected Cells Human renin gene expression was evaluated by transient DNA transfections into two cell types derived from human chorionic tissue: chorionic cells in secondary culture, which expressed the renin gene to a high extent (renin content of the culture medium measured by ELISA reached 20 ng - mL- 1 24 hours-1), and JEG-3 cells, which did not express it (no renin detected in the culture medium). Plasmids containing the 5'flanking region of the human renin gene (up to + 16 relative to the transcription start site) were fused to the luciferase reporter gene, which was preferred to the CAT gene because of its higher sensitivity.31 To normalize for plate-to-plate differences in transfection efficiency, a reporter plasmid RSV-CAT was cotransfected and assayed independently. Luciferase activity was normalized to the cotransfected internal control RSV-CAT and plotted as a percentage of the RSV luci signal for each transfection. Fig 1 shows the basal activity of the renin promoter. In chorionic cells, there was a moderate but not significant decrease in luciferase activity with shorter plasmids from p2616+ to p582+. The basal luciferase activities of p582+, p892+, and p2616+ were 4.65%, 7.26%, and 8.43% of RSV luci, respectively. This suggests that major basal cis-regulatory elements are located downstream -582 bp. Two controls were performed: (1) The antisense plasmid p582- did not express luciferase activity (0.1+0.1%, n=2) compared with the sense plasmid p582+ (4.65±2.08%, n=6). (2) In JEG-3 cells, the renin lu- transfected RSV-CAT activity. Results are given as mean±SEM of the percentage of RSV luciferase activity to adjust for differences in transfection efficiency. Each bar representsin two to five indepenluciS p582- *dent transfections triplicate flasks. ciferase fusion reporter gene displayed very low activity (0.23%, 0.17%, and 0.04% of RSV luci for the same plasmids, respectively) compared with that in chorionic cells. To locate cis-regulatory elements, sequential deletions of the 5'-flanking region of the p582+ plasmid were performed, and the resulting renin-luciferase constructs were transfected into chorionic cells. Results were expressed as percentage of the activity of the p582+ plasmid to normalize the results of different transfections. Fig 2 shows that progressive 5'-deletions extending to nucleotide - 374 had no effect on promoter activity. In contrast, deletions extending to nucleotide -273 gave a twofold stimulation above that of the renin 5'-flanking region of 582 bp. Further deletion of sequences between -273 and -67 greatly increased promoter activity: the plasmids pl37+, p110+, and p67+ demonstrated threefold to fivefold increases in luciferase activity compared with p582+ plasmid. The specificity of the renin promoter activity was confirmed by the very low luciferase activity observed with the p110- plasmid, where the renin DNA was inserted in the antisense orientation. The 5'-sequences within p110+ were sufficient to direct specific expression of this renin gene construct in the chorionic cells, since JEG-3 cells transfected with p110+ plasmid did not exhibit the same high level of expression as identically transfected chorionic cells (Table). The p67+ plasmid demonstrated a 1.6-fold increase in luciferase activity, suggesting that the 67 bp of renin promoter are not sufficient to direct specific expression of renin gene. Smith and Morris18 described that JEG-3 cells expressed no detectable renin mRNA by Northern blot % relative luciferase activity 0 ` -582 16 164 o(.-582 -455 -273 - *> > -110 > -137 +16 -110 -67 100 200 p582i p582 p501 > > -501 FIG 1. Bar graph showing transient transfection analysis of renin/luciferase (luci) constructs in chorionic and JEG-3 cells. Transient cotransfections of renin/ luciferase and RSV-chloramphenicol acetyl transferase (CAT) reporter gene - 400 500 600 fected into human chorionic cells. Luciferase activity was normalized to cotransfected RSV-chloramphenicol acetyl transferase activity, and the results (mean+SEM) are given as per- + p455+ p374+ p273. pl 37+ p110+ p110 p67+ 300 FIG 2. Bar graph showing 5-deletion analysis of the human renin gene promoter. 5-Deletion of the p582+ plasmid was performed by exonuclease Ill as described in "Materials and Methods." Plasmid constructs were trans- _ centage of p582+ lucferase activity. box represents a minimum of t~~~~~~~~~~ach three independent transfections in triplicate flasks, except for plasmids p582- and p110- (two independent transfections). 768 Circulation Research Vol 74, No S May 1994 Relative Luciferase Activity of Renin Promoter Deletions in Chorionic and JEG-3 Cells Chorionic Cells JEG-3 n n Plasmid %±SEM %±SEM 100 7 100 3 p582+ p110+ 6 3 346+58 123+4 476+58 3 167 22 3 p67+ activity was normalized to cotransfected RSVLuciferase chloramphenicol acetyl transferase activity, and the results (mean+SEM) are given as percentage of p582+ luciferase activity. n represents the number of independent transfections in triplicate flasks. Downloaded from http://circres.ahajournals.org/ by guest on August 3, 2017 analysis, and little renin mRNA detected by PCR compared with chorionic cells (Fig 3) confirmed these data. Moreover, by quantitative reverse transcriptase PCR, we showed that renin mRNA from JEG-3 cells represented 0.3% of renin mRNA from chorionic cells (data not shown). Finally, the exact site of transcription driven by the renin/luciferase fusion gene constructs was determined by primer extension. The p582+ and p110+ plasmids were transfected into chorionic cells, the RNA was extracted, and the transcriptional initiation site was mapped by primer extension experiments. One major fragment was obtained with both plasmids, confirming the correct initiation of transcription (data not shown). Footprint Analysis of the Human Renin Promoter Changes in the expression of the serial deleted renin/ luciferase genes (p582+ to p67+) suggest that factors within chorionic cells interact with renin cis-acting sequences. To demonstrate that these regulatory regions involved in the expression of the renin gene are sites for contact with DNA binding proteins from chorionic cells, the promoter sequence spanning -336 to + 16 was subjected to DNase I footprint analyses in the presence and absence of nuclear extracts from human chorionic cells. This study showed the presence of six footprints, designated A through F (Fig 4). Footprint A comprised sequences from -29 to -6 and contained a centrally located, purine-rich sequence (GGAA) shown to be a conserved recognition site for ets-domain proteins.32 Footprint B, which extended from -79 to -62, was homologous with the Pit-I binding site consensus sequence A(A/T)TTANCAT.33 Footprint C (from -107 to -83) did not show any sequence homology with previously described regulatory elements. Footprint D, from -234 to -214, showed strong homology with the CRE, TGACGTCA.3(1 Footprint E extended from -259 1 2 3 4 -._^ 243bp FIG 3. Northern blot analysis of renin mRNA by reverse transcriptase polymerase chain reaction (PCR) in chorionic cells (lanes 1 and 3) and JEG-3 cells (lanes 2 and 4). Total RNA 50 ng (lanes 1 and 2) and 500 ng (lanes 3 and 4) were subiected to reverse transcription and PCR amplification, electrophoresed on 8% acrylamide gel, and autoradiographed for 3 hours. to -245, and its sequence was similar to the binding site for the ARP-1.34 Footprint F, from 293 to 272, showed strong homology with the sequence AGE3 described recently by Tamura et aP35 on the human angiotensinogen gene. Functionality of the CRE Element The functionality of the CRE in the renin promoter in chorionic cells was further assessed by two methods: (1) transient DNA transfections performed in the presence of forskolin and (2) gel mobility shift analysis using the renin CRE-like sequence and chorionic cell extracts. Transient DNA transfections were performed with the different constructs described above, and the cells were treated or not treated with 10` mol/L forskolin for 24 hours. All transfections were performed in the absence of FCS to avoid nonspecific interference in renin gene expression. Fig 5 shows a clear twofold to threefold increase of promoter activity within the region -2616 to -273. With the p137+ and p110+ plasmids, which lack element D (-234 to -214), there was only modest stimulation of promoter activity (1.81±0.2 P<.05, and 1.62±0.28, P=NS, respectively). No significant stimulation was observed with the p67+ plasmid. The promoterless plasmid, BS luci, was not stimulated by forskolin (0.96 of unstimulated luciferase activity), demonstrating that the induction of luciferase activity in cells transfected with the renin/ luciferase constructs was mediated only via the renin promoter sequence. Finally, the specific interaction of chorionic cell nuclear factors with element D (containing the CRE-like sequence) was investigated using gel mobility shift analysis. Double-stranded oligonucleotide containing element D was used as a labeled probe. Two protein/ DNA complexes (Fig 6, arrows) were observed that were specifically competed by an excess of either homologous unlabeled DNA (REN) or somatostatin (SMS) oligonucleotide containing the consensus CRE. Both REN and SMS probe were able to completely compete the chorionic cell nuclear binding protein. This suggested that a CRE binding protein (CREB)-like substance interacted with element D of renin promoter. Discussion Since the structure of the human renin gene was first determined,625 several studies have been carried out to identify the cis-regulatory elements that control its transcriptional activity. Because human renin gene expression very likely depends on transcriptional regulatory factors present only in renin-expressing cells, it is important to perform such studies in cell lines that express renin. Cells derived from chorionic tissue are a major extrarenal site of renin production after kidney tissue.8"^" Human chorionic cell cultures have been characterized by Pinet et al,14 who used electron microscopy to show that these cultures contained a single type of elongated cell. Immunofluorescence studies using specific renin antibodies have shown that all cells in culture were stained and therefore contained both renin and prorenin. Chorionic cells in culture produce predominantly prorenin, and they seem to have only the constitutive pathway. Nevertheless, even though the chorionic cell in culture does not process prorenin, this model could be used to study renin gene transcription. Borensztein et al cis-Acting Elements in the Human Renin Gene 76 769 U G T 1 23 0. [c] ate Zr: Pt? -# [B] t a S . -. U AZ ,.a V .I* . .. .4 GT AW- 1 5 FIG 4. DNase footprinting of the 5-proximal region of the human renin gene C 336 to + 16). Footprint analysis was performed with human chorionic cell nuclear extracts. Binding reactions and DNase treatment were carried out as described in "Materials and Methods." G and T represent the sequencing ladder. In panels through Ill, lane 1 shows the reaction performed without nuclear extract; lanes 2 and 3, the reactions performed with 30 gig of nuclear extract and decreasing amounts of DNase 1. Panel 1, DNase footprinting analysis of the noncoding strand of the -336 to +16 fragment. Panels II and Ill, DNase footprinting analysis of the coding strand of the -336 to ± 16 fragment. Panel IV, sequences (A through F, in boxes) of the DNase I-protected regions of the human renin promoter in the presence of human chorionic cell nuclear extract. C Downloaded from http://circres.ahajournals.org/ by guest on August 3, 2017 '4 *4' K1 4- .A fl.p.) n f 1* *t f la Iv -364 GGGGTTGGGTCTGGGGIAGGGAGCTGGAAACGIAGGITTTTACGCGTTGTCCGAGITTITGAT F E -3Q4 GTTAGCCCTG GCAGIGGIGITIGITCATGAGG TCTGCGIGCTC AGGGGTGAGAGGG~CD AGGGCTGCIAGCGIGACIGG[AACAAGAITGGITIGGGCACAGGTGTGGI -184 ICCIGGAGGGCCTCTGCTGGGCAIGGGGAAACGTGGGTACGGIIGACCCACCTAGTCI'GG -244 AAGCCAGAIA B c -124 TCGCGC AGIGAGTTTTATIGGITGAC TGC CCITGCGCATCITAC CC AG~GIAAIAAATGAG GG 643GCAGAATTGCAATGACCCCATGCATGGAGT IATAAAAGGGGAAGGGGCTAAGGG G -4 CCACAGAACCICAGIGGAIC +1 Human chorionic cells are a suitable model to study the transcriptional regulatory elements involved in renin gene expression: (1) These cells synthesized large amounts of prorenin. Their renin mRNA was identical in size (1.6 kb) to that of kidney renin mRNA14,16 and was easily detectable by Northern blot analysis. In contrast, in non-reninproducing cells, JEG-3 cells, renin mRNA could be detected only slightly by PCR. (2) A highest luciferase activity (between 20- and 200-fold) of renin promoter! luciferase constructs was obtained with chorionic cells compared with JEG-3 cells by transient DNA transfection. This finding in JEG-3 cells is in agreement with the results of Smith and Morris,'8 who showed that, in JEG-3 cells, the human renin promoter was not able to direct CAT transcription in the absence of the herpes simplex virus tk promoter. The CAT activity detected when the renin promoter region was fused to the tk promoter17'18might have been driven by the tk promoter, which is more potent than the renin promoter. In contrast, Duncan et al'6 reported that human chorionic cells are capable of using the first 600 bp of the renin promoter to direct CAT expression. (3) A correct initiation of transcription was found with renin/luciferase fusion genes transfected within chorionic cells. 770 Circulation Research Vol 74, No 5 May 1994 Forskolin stimulation (fold increase) 0 t BS Luci TagCGTCA --> +16 p2616+ --~ >6p2+ / -2616 mi---- -892 -582 . 2 1 ._ I 3 4 __j EEEH p892+ p582+ -273 t-- p273+ -137 p137+ -110 p110+ -67 * p67+ Downloaded from http://circres.ahajournals.org/ by guest on August 3, 2017 FIG 5. Bar graph showing effects of 10-5 mol/L forskolin on the expression of the human renin promoter. The different renin/luciferase constructs were transfected into chorionic cells and assayed for luciferase activity after 24 hours of 10-5 mol/L forskolin stimulation. Luciferase activity was normalized to cotransfected RSV-chloramphenicol acetyl transferase activity. Results (mean -+-SEM) are given as forskolin-induced fold increases in basal unstimulated luciferase activity. The luciferase activity of the control plasmid, BS luci, was not stimulated by forskolin (0.96 of unstimulated luciferase activity). Each box represents two to five independent transfection experiments in triplicate flasks. The presence of the putative cAMP-responsive element (-226/-219) is indicated by the black marker on the various constructs. In the present study, no major basal regulatory elements were detected upstream of -582 up to -2616. In contrast, deletion analysis of the 5'-flanking region of the p582+ plasmid revealed that the first 110 bp of the renin promoter were sufficient for a specific and high expression in human chorionic cells (more than threecompetitor t: b -l I SMS REN a) 0 nc a 0 tin 0 N" c' oh 01% - 0 Ce in 04 W #, wsst.qmmu.mm FIG 6. Gel mobility shift analysis of chorionic cell nuclear factor interactions with the human renin promoter (-234/-200). A double-stranded synthetic oligonucleotide including the footprint D was used as the probe. Competitions were performed with homologous DNA (REN) or with the somatostatin (SMS) oligonucleotide.30 Arrows indicate the specific DNA/protein complexes. The fold molar excess of competitor is indicated for each competitor sequence. fold higher than p582+) and could therefore correspond to the "basal promoter." Indeed, this highest activity is not due to plasmid "read-through" artifact, since the activity of the shortest 5'-flanking DNA fragment (p110+ and p67+) was not increased when transfected into a non-renin-producing cell line, the JEG-3 cells. A negative regulatory element was found between the -374 and -273 bp by deletion analysis of the 582 bp of renin promoter. DNase I footprinting showed that this region of DNA binds trans-activating factors present in chorionic cellular nuclear extract. This footprint has strong homology with a sequence of the mouse angiotensinogen gene that binds the constitutive factor named AGF3 by the authors.35 They suggested that AGF3 could play important roles in the differentiationdependent promoter activation of the mouse angiotensinogen gene in adipocytes. In the case of the human renin promoter, the present results suggested that an "AGF3-like" protein from chorionic cells could repress human renin expression. Further deletions of the 5'region until -137 bp revealed the presence of another negative regulatory element. Interestingly, the DNase I protection assay revealed that this region contains a sequence, footprint E (-259 to -245), that binds nuclear extract from chorionic cells. This putative ciselement has strong homology with a sequence of the human apolipoprotein AI gene that binds the ubiquitous ARP-1,34 a member of the orphan steroid receptor superfamily that decreases apoAl gene expression. These results suggest that an ARP-1-like protein might decrease renin gene expression in chorionic cells. Both negative elements found in chorionic cells are not operative in JEG-3 cells, since the p10O+ plasmid did not exhibit a highest activity, suggesting that these trans-acting factors, AGF3 and ARP-1, may not be present in these latter cells. No difference in luciferase activity was found with the plasmids pl37+ and p110+ in relation to the fact that no footprint was found between -137 and -110 bp of the human renin promoter. Further deletions until -67 bp showed an increase in luciferase activity. This DNA Borensztein et al cis-Acting Elements in the Human Renin Gene A. 4) 40 A.. -107/-83 -791-62 -291-6 c' Ii = -2931-272 -2591-245 -23d41-214 F E D A ARen Ets Cons. Ren C Pit-1 Cons. ATGNATAAWT D CRE Cons. Ren GAGGGCTGCTAGCGTCACTGG TGACGTCA Ren AGGGGTCACAGGGCC E ARP-1 Cons. F Ren GGAW FIG 7. Schematic representation of the hurenin promoter. The stippled boxes are the protein-binding sites identified by DNase footprinting analysis. For each footprint (A--F), renin sequence was aligned to possible factor binding site consensus sequence. Boldface letters in renin sequence represent homology with the consensus sequence. W=A+T, N=G+A+T+C. LUCI indicates luciferase; ARP-1, apolipoprotein Al regulatory protein-i; CRE, cAMP-responsive element; and Pit-1, pituitary-specific factor. man AGGGGTCA-AGGGNTCA GCAGTGCT-GTTTCTCATCAGCC AGCTGTGCTTGT Downloaded from http://circres.ahajournals.org/ by guest on August 3, 2017 region binds two factors: one named element C, which did any homology with previously described regulatory elements; the other, element B, is an adenine/ thymine rich region very similar to the Pit-1 binding site consensus sequence.33 Recently, Sun et a120 showed that this region of the human renin promoter binds nuclear extracts isolated from GC cells, a pituitary lactotrope precursor cell line. Furthermore, they showed that the activity of the renin promoter/luciferase constructs transfected into HeLa cells was greatly increased by cotransfection with a Pit-1 expression vector. Pit-1, a specific pituitary factor, is a member of the POU family of transcription factors, which plays a critical role in the proliferation of specific cells and in their expression of specific genes.36 In contrast to the results of Sun et a120 in GC cells, deletion of this Pit-i-like binding site did not affect luciferase gene expression in chorionic cells. This suggests cell-specific use of this regulatory element. Such an observation, concerning the differential expression of a promoter in different cell lines, has been made by Paulweber et a137 for the apolipoprotein B promoter in HepG2 (hepatic) and CaCo-2 (intestinal) cell lines. They showed that this difference was due to the relative amounts of nuclear factors that bind to specific sequences located within the promoter. Another explanation for this discrepancy could be the presence, in chorionic cells, of a nuclear factor binding the downstream element A (-29 to -6 bp), which contains the consensus GGAA ets motif.32 Many of the ets-domain proteins have been shown to be transcription activators in various tissues.32 Thus, the high luciferase activity of plasmid p67+ might result from the presence, in chorionic cells, of an ets-domain protein involved in the expression of the human renin gene. This domain might be not operative in GC cells. The functionality of the renin promoter was further assessed by forskolin stimulation. Previous studies by Duncan et a138 had shown that, in chorionic cells, plasmid constructs containing either the first 600 or 100 bp of the human renin promoter fused to CAT were markedly stimulated by 8 hours of incubation with 10-6 mol/L forskolin. In contrast, plasmids containing the '-flanking region of the renin gene (from - 584 to -146 and from -146 to + 11) fused to the tk promoter were not share A GGTAATAAATCAGGGCAG B AGE3 Cons. B +1 +16 TATAAAAGGGGAAGGGC TAAGGGA GGAW 771 not induced by forskolin.38 However, these experiments performed in the presence of FCS, which is capable of stimulating the transcription of several genes via different serum response elements.39 cAMP might also activate serum response elements,40 and therefore, interactions between serum- and cAMP-induced stimulation could not be excluded. In JEG-3 cells, Burt et al17 had also used plasmids containing the 5'-flanking region of the renin gene fused to the tk promoter and reported a modest 60% cAMP-induced stimulation. It was for these reasons that further studies on the effects of cAMP on renin gene expression were required. In the present study, all stimulations were performed in the absence of FCS to avoid nonspecific interference. The results show that element D (-234 to -214) was required for forskolin to stimulate transcription twofold to threefold. This element contains a motif, TAGCGTCA, that shares a six-nucleotide homology with the consensus CRE octamer TGACGTCA.30 It contains the short motif CGTCA, which has been shown to be a binding site for CREB.41 The present results show that nuclear extracts isolated from chorionic cells bound to this sequence. Two specific DNA/protein complexes were found and could result from the formation of monomeric and dimeric DNA/protein complexes as previously described.42 In addition, this DNA/protein binding was displaced by the SMS oligonucleotide containing the consensus binding site for CREB.30 Taken together, these results are in favor of element D being a functional CRE site. However, the modest forskolin-stimulated increase in luciferase activity observed with constructs p137+ and pl10+ (50%) cannot be explained by this CRE-like sequence. Interestingly, Peers et a143 have shown that Pit-1 is involved in the cAMP stimulation of the human prolactin gene and that several Pit-1 binding sites fused to the tk promoter confer cAMP responsiveness to GC cells. It is therefore possible that the Pit-i-like binding site present on the renin gene is also involved in regulation by cAMP and that stimulation by cAMP is the result of multiple responses acting in combination to yield a measurable degree of stimulation. Further studies will be necessary to determine whether the Pit-i-like sequence is necessary to confer cAMP responsiveness on the renin gene. were 772 Circulation Research Vol 74, No 5 May 1994 Downloaded from http://circres.ahajournals.org/ by guest on August 3, 2017 Overall, these results clearly identify several functional cis-regulatory regions in the renin gene and potential trans-activating factors governing renin gene expression in human chorionic cells as represented schematically in Fig 7. No studies have yet been reported in human JG cell regulation of renin transcription because of the lack of suitable cell lines or cell culture models. However, like chorionic cells, JG cells respond to forskolin by an increase in renin mRNA and renin release,44 and factors similar or identical to the CREB identified in the present study could be involved. Moreover, chorionic cells in culture respond to angiotensin II by an elevation of intracellular calcium and a decrease in renin production (unpublished data) like JG cells.2 However, characterization of transcription factors that bind human renin promoter from kidney cortex or juxtaglomerular cells would permit determination of renin-producing cell-specific factors. We can speculate that some of the transcription factors characterized could be implied in the renin tissue-specific expression and in renin regulation in vivo. Acknowledgments We wish to thank Dr A. Fukamizu and Dr S. Subramani for having kindly provided the renin and RSV luciferase plasmids, respectively. The authors are grateful to Dr M. Day for editorial help and to Nicole Braure for secretarial assistance. We wish to thank G. Masquelier and A. BoisquilIon for artwork. References 1. Hackenthal E, Paul DG, Taugner R. Morphology, physiology, and molecular biology of renin secretion. Physiol Rev. 1990;70: 1067-1116. 2. Kurtz A. Cellular control of renin secretion. Rev Physiol Biochem Pharmacol. 1989;113:1-40. 3. Nakamura N, Burt DW, Paul M, Dzau VJ. Negative control elements and cAMP responsive sequences in the tissue-specific expression of mouse renin genes. Proc Natl Acad Sci US A. 1989; 86:56-59. 4. Barret G, Horiuchi M, Paul M, Pratt RE, Nakamura N, Dzau VJ. Identification of a negative regulatory element involved in tissuespecific expression of mouse renin genes. Proc NatlAcad Sci U SA. 1992;89:885-889. 5. Tamura K, Tanimoto K, Murakami K, Fukamizu A. A combination of upstream and proximal elements is required for efficient expression of the mouse renin promoter in cultured cells. Nucleic Acids Res. 1992;14:3617-3623. 6. Soubrier F, Panthier JJ, Houot AM, Rougeon F, Corvol P. Segmental homology between the promoter region of the human renin gene and the mouse Renl and Ren2 promoter regions. Gene. 1986;41:85-92. 7. Deboben A, Inagami T, Ganten D. Tissue renin. In: Hypertension: Physiopathology and Treatment. New York, NY: McGraw-Hill; 1983:194-209. 8. Acker GM, Galen FX, Devaux C, Foote S, Papernik E, Pesty A, Menard J, Corvol P. Human chorionic cells in primary culture: a model for renin biosynthesis. J Clin Endocrinol Metab. 1982;55: 902-909. 9. Poisner AM, Wood GM, Poisner R, Inagami T. Localization of renin in trophoblasts in human chorion leave at term pregnancy. Endocrinology. 1981;109:1150-1155. 10. Skinner SL, Lumbers ER, Symonds EM. Renin concentration in human fetal and maternal tissues. Am J Obstet Gynecol. 1968;101: 529-533. 11. Conn JW, Cohen EL, Lucas CP, McDonald WJ, Mayor GH, Blough WM, Eveland WC, Bookstein JJ, Lapides J. Primary reninism. Arch Intern Med. 1972;130:682- 696. 12. Galen FX, Corvol MT, Devaux C, Gubler MC, Mounier F, Camilleri JP, Houot AM, Menard J, Corvol P. Renin biosynthesis by human tumoral juxtaglomerular cells: evidences for a renin precursor. J Clin Invest. 1984;73:1144-1155. 13. Pinet F, Corvol MT, Dench F, Bourguignon J, Feunteun J, Menard J, Corvol P. Isolation of renin-producing human cells by transfection with three simian virus 40 mutants. Proc Natl Acad Sci USA. 1985;82:8503-8507. 14. Pinet F, Corvol MT, Bourguignon J, Corvol P. Isolation and characterization of renin-producing human chorionic cells in culture. J Clin Endocrinol Metab. 1988;67:1211-1220. 15. Poisner AM, Agrawal P, Poisner R. Renin release from human chorionic trophoblasts in vitro. Trophoblast Res. 1987;2:45-60. 16. Duncan KG, Haidar MA, Baxter JD, Reudelhuber TL. Control elements in the human renin gene. Trans Am Assoc Phys. 1987; 100:1-9. 17. Burt DW, Nakamura N, Kelley P, Dzau VJ. Identification of negative and positive regulatory elements in the human renin gene. J Biol Chem. 1989;264:7357-7362. 18. Smith DL, Morris BJ. Transient expression analyses of DNA extending 2.4 kb upstream of the human renin gene. Mol Cell Endocrinol. 1991;80:139-146. 19. Ekker M, Sola C, Rougeon F. The activity of the mouse renin promoter in cells that do not normally produce renin is dependent upon the presence of a functional enhancer. FEBS Lett. 1989;255: 241-247. 20. Sun J, Oddoux C, Lazarus A, Gilbert MT, Catanzaro DF. Promoter activity of human renin 5'-flanking DNA sequences is activated by the pituitary-specific transcription factor Pit-1. J Biol Chem. 1993;268:1505-1508. 21. Ingraham HA, Chen R, Mangalam HJ, Elsholtz HP, Flynn SE, Lin CR, Simmons DM, Swanson L, Rosenfeld MG. A tissue-specific transcription factor containing a homeodomain specifies a pituitary phenotype. Cell. 1988;55:519-529. 22. Graham FL, Van Der Eb AJ. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 1975;52: 456-476. 23. Menard J, Bews J, Heusser C. A multirange ELISA for the measurement of plasma renin in humans and primates. J Hypertens. 1984;2(suppl 3):275-279. 24. N'Guyen VT, Morange M, Bensaude 0. Firefly luminescence assays using scintillation counters for quantitation in transfected mammalian cells. Anal Biochem. 1988;171:404-408. 25. Fukamizu A, Nishi K, Nishimatsu S, Miyazaki H, Hirose S, Murakami K. Human renin gene of renin-secreting tumor. Gene. 1986;49:139-145. 26. De Wet JR, Wood KV, Deluca M, Helinski DR, Subramani S. Firefly luciferase gene: structure and expression in mammalian cells. Mol Cell Biol. 1987;7:725-737. 27. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159. 28. Caroff N, Della Bruna R, Philippe J, Corvol P, Pinet F. Regulation of human renin secretion and renin transcription by quantitative PCR in cultured chorionic cells: synergistic effect of cyclic AMP and protein kinase C. Biochem Biophys Res Commun. 1993;193: 1332-1338. 29. Shapiro DJ, Sharp PA, Wahli WW, Keller M. A high efficiency Hela cell nuclear transcription extract. DNA. 1988;7:47-55. 30. Montminy MR, Sevarino KA, Wagner JA, Mandel G, Goodman RH. Identification of a cyclic-AMP-responsive element within the somatostatin gene. Proc Natl Acad Sci U SA. 1986;83: 6682-6686. 31. Alam J, Cook JL. Reporter genes: application to the study of mammalian gene transcription. Anal Biochem. 1990;188:245-254. 32. Wasylyk B, Hahn SL, Giovane A. The Ets family of transcription factors. EurJBiochem. 1993;211:7-18. 33. Nelson C, Albert VR, Elsholtz HP, Lu LIW, Rosenfeld MG. Activation of cell-specific expression of rat growth hormone and prolactin genes by a common transcription factor. Science. 1988; 239:1400-1405. 34. Ladias JAA, Karathaniasis SK. Regulation of the apolipoprotein AI gene by ARP-1, a novel member of the steroid receptor superfamily. Science. 1991;251:561-565. 35. Tamura K, Tanimoto K, Ishii M, Murakami K, Fukamizu A. Proximal and core DNA elements are required for efficient angiotensinogen promoter activation during adipogenic differentiation. J Biol Chem. 1993;268:15024-15032. 36. He X, Treacy MN, Simmons DM, Ingraham HA, Swanson BW, Rosenfeld MG. Expression of a large family of POU-domain regulatory genes in mammalian brain development. Nature. 1989;340: 35-42. 37. Paulweber B, Onasch MA, Nagy BP, Levy-Wilson B. Similarities and differences in the function of regulatory elements at the 5' end Borensztein et al cis-Acting Elements in the Human Renin Gene 38. 39. 40. 41. of the human apolipoprotein B gene in cultured hepatoma (HepG2) and colon carcinoma (CaCo-2) cells. J Biol Chem. 1991; 266:24149-24160. Duncan KG, Haidar MA, Baxter JB, Reudelhuber TL. Regulation of human renin expression in chorion cell primary cultures. Proc Natl Acad Sci USA. 1990;87:7588-7592. Faisst S, Meyer S. Compilation of vertebrate-encoded transcription factors. Nucleic Acids Res. 1992;20:3-26. Fukumoto Y, Kaibuchi K, Oku N, Hori Y, Takai Y. Activation of the c-fos serum-response element by the activated c-Ha-ras protein in a manner independent of protein kinase C and cAMPdependent protein kinase. J Biol Chem. 1990;265:774-780. Nichols M, Weih F, Schmid W, De Vack C, Kowenz-Leutz E, Luckow B, Boshart M, Schuitz G. Phosphorylation of CREB affects 773 its binding to high and low affinity sites: implications for cAMP induced gene transcription. EMBO J. 1992;11:3337-3346. 42. Yamamoto KK, Gonzales GA, Biggs WH, Montminy MR. Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREB. Nature. 1988;334:494-498. 43. Peers B, Monget P, Nalda MA, Voz ML, Berwaer M, Belayew A, Martial JA. Transcriptional induction of the human prolactin gene by cAMP requires two cis-acting elements and at least the pituitary-specific factor Pit-i. J Biol Chem. 1991;266: 18127-18134. 44. Della Bruna R, Kurtz A, Corvol P, Pinet F. Renin mRNA quantification using polymerase chain reaction in cultured juxtaglomerular cells. Circ Res. 1993;73:639-648. Downloaded from http://circres.ahajournals.org/ by guest on August 3, 2017 cis-regulatory elements and trans-acting factors directing basal and cAMP-stimulated human renin gene expression in chorionic cells. P Borensztein, S Germain, S Fuchs, J Philippe, P Corvol and F Pinet Downloaded from http://circres.ahajournals.org/ by guest on August 3, 2017 Circ Res. 1994;74:764-773 doi: 10.1161/01.RES.74.5.764 Circulation Research is published by the American Heart Association, 7272 Greenville Avenue, Dallas, TX 75231 Copyright © 1994 American Heart Association, Inc. All rights reserved. Print ISSN: 0009-7330. Online ISSN: 1524-4571 The online version of this article, along with updated information and services, is located on the World Wide Web at: http://circres.ahajournals.org/content/74/5/764 Permissions: Requests for permissions to reproduce figures, tables, or portions of articles originally published in Circulation Research can be obtained via RightsLink, a service of the Copyright Clearance Center, not the Editorial Office. Once the online version of the published article for which permission is being requested is located, click Request Permissions in the middle column of the Web page under Services. Further information about this process is available in the Permissions and Rights Question and Answer document. Reprints: Information about reprints can be found online at: http://www.lww.com/reprints Subscriptions: Information about subscribing to Circulation Research is online at: http://circres.ahajournals.org//subscriptions/